Could a shot for moms shield babies from deadly RSV?
NCT ID NCT06955728
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This large study tests an RSV vaccine given to pregnant women to see if it safely protects their babies from severe RSV infection in the first months of life. About 13,000 pregnant women in Africa will receive either the vaccine or a placebo. The study also closely monitors whether the vaccine increases the risk of preterm birth, which was seen in earlier trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RSV vaccine (RSVpreF, brand name ABRYSVO)
- What this could lead to
- If successful, this could confirm that vaccinating pregnant women safely protects infants from severe RSV, reducing hospitalizations and deaths in low- and middle-income countries.
- What could go wrong
- Previous studies showed a slightly higher rate of preterm births in vaccinated women, though babies were born only a few weeks early and survived. This trial is needed to clarify that risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM LABOUR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dodowa Health Research Centre
NOT_YET_RECRUITINGDodowa, Greater Accra Region, Ghana
-
Enhancing Care Foundation
RECRUITINGDurban, KwaZulu-Natal, 4052, South Africa
-
Kenya Medical Research Institute Centre for Global Health Research
RECRUITINGKisumu, Nyanza, 40100, Kenya
-
Kenya Medical Research Institute Wellcome Trust
NOT_YET_RECRUITINGKilifi, Kilifi County, 230-80108, Kenya
-
Kintampo Health Research Centre
NOT_YET_RECRUITINGKintampo, Bono East, Ghana
-
MRC Unit The Gambia at London School of Hygiene & Tropical Medicine
RECRUITINGBasse Santa Su, Upper River Division, The Gambia
-
MRC Unit on Child and Adolescent Health
RECRUITINGRondebosch, Western Cape, 7700, South Africa
-
Setshaba Research Centre
RECRUITINGSoshanguve, Gauteng, 0152, South Africa
-
VIDA Nkanyezi Research Unit
RECRUITINGJohannesburg, Gauteng, 2093, South Africa
-
Wits RHI Shandukani CRS
RECRUITINGHillbrow, Gauteng, 2001, South Africa
-
Wits Vaccines & Infectious Diseases Analytics (VIDA) Research unit
RECRUITINGSoweto, Gauteng, 1864, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breath test catch flu in High-HIV regions?
- New study tracks immune clues in seniors with flu, RSV, and COVID-19
- RSV drug trial for kids under 5 halted early – only 4 children enrolled
- RSV study seeks immune clues in older adults
- France launches massive virus surveillance in GP clinics
- New study aims to predict severe bronchiolitis in infants